Boston Scientific (BSX) Tops Q3 EPS by 4c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Boston Scientific (BSX) PT Raised to $98 at RBC Capital
October 24, 2024 6:37 AM EDTRBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $98.00 (from $95.00) while maintaining a Outperform rating.
The analyst comments "BSX reported impressive Q3'24 results (+18% y/y organic or 1,120bps above end-markets, and 26% y/y EPS growth)... More
CL King Reiterates Buy Rating on Boston Scientific (BSX)
October 24, 2024 6:34 AM EDTCL King analyst Kristen Stewart reiterated a Buy rating and $90.00 price target on Boston Scientific (NYSE: BSX)
The analyst comments "Boston Scientific (BSX) reported 3Q24 results that came in well above consensus expectations. We expect the stock to react favorably to the... More
